Study on Bacterial Biofilm-Targeted Smart Drug Delivery System
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".
Deadline for manuscript submissions: 10 June 2024 | Viewed by 93
Special Issue Editors
Interests: nanoparticle synthesis; ROS science; cancer treatment; dental research; biofilms
Special Issue Information
Dear Colleagues,
Bacterial biofilm formation is involved in the pathogenesis of many diseases and is responsible for up to 80% of all human bacterial infections. Biofilms are complex, multicellular communities of bacteria that adhere to surfaces and are highly protected by a self-produced extracellular matrix. The matrix contributes to the high virulence and tolerance of biofilms to antibiotics by restricting drug penetration, diffusion and limiting the retention of antibiotics. The persistent nature of these biofilms, coupled with their inherent resistance to traditional antimicrobial therapies, underscores a pressing clinical challenge—these biofilms often evade eradication, leading to recurrent treatment failures. In response to this urgent issue, there is a growing emphasis on the exploration of smart drug carriers. These innovative platforms are being investigated for their potential to effectively penetrate biofilms, thereby enhancing the efficacy of antimicrobials while simultaneously minimizing the adverse effects associated with current treatments. This Special Issue aims to serve as an esteemed forum for the congregation of distinguished scientists globally, fostering an environment of collaborative exploration and innovation. By presenting a convergence of groundbreaking research and cutting-edge strategies, we aspire to catalyze advancements in combating persistent bacterial infections. We are seeking submissions of both review and original research articles that contribute novel insights and empirical findings related to the targeted delivery of drugs to bacterial biofilms.
We look forward to receiving your contributions.
Dr. Nil Kanatha Pandey
Dr. Zhenting Xiang
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- drug delivery system
- antibiofilm therapy
- smart carriers
- biomaterials
- triggered drug release
- bacterial biofilms
